Cargando…
Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosis
Treatment-related acute myeloid leukaemia (t-AML) is a serious complication of topoisomerase 2 inhibitor therapy and is characterised by the presence of mixed lineage leukaemia (MLL) rearrangement. By molecular tracking, we were able to show that MLL cleavage preceded gene rearrangement by 3 months...
Autores principales: | Ng, A, Ravetto, P F, Taylor, G M, Wynn, R F, Eden, O B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409780/ https://www.ncbi.nlm.nih.gov/pubmed/15570305 http://dx.doi.org/10.1038/sj.bjc.6602269 |
Ejemplares similares
-
Lamotrigine: Haemophagocytic lymphohistiocytosis: case report
Publicado: (2022) -
Alemtuzumab: Haemophagocytic lymphohistiocytosis: case report
Publicado: (2021) -
Histoplasmosis, heart failure, hemolysis and haemophagocytic lymphohistiocytosis
por: Gupta, Nitin, et al.
Publicado: (2019) -
Hereditary haemochromatosis, haemophagocytic lymphohistiocytosis and COVID-19
por: Riley, Matthew J., et al.
Publicado: (2020) -
Haemophagocytic lymphohistiocytosis secondary to intrauterine
cytomegalovirus infection
por: Pessoa, Fabrício Silva, et al.
Publicado: (2021)